Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance.

Cellular and molecular life sciences : CMLS - 1 Jul 2006

Woodrow C J, Krishna S

Abstract excerpt

Molecular determinants of antimalarial drug resistance are useful and informative tools that complement phenotypic assays for drug resistance. They also guide the design of strategies to circumvent such resistance once it has reached levels of clinical significance. Established resistance to arylaminoalcohols such as mefloquine and lumefantrine in SE Asia is mediated primarily by gene amplification of the P....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artemisinins
Share to Asia, Southeastern
Share to Calcium-Transporting ATPases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chloroquine

Share to Mefloquine

Share to Multidrug Resistance-Associated Proteins

Share to Quinine

Share to Sesquiterpenes

Source

Open in PubMed Open full text

Identifiers

PMID: 16699808
DOI: 10.1007/s00018-006-6071-1
PMCID: PMC11136207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance.PMID 16699808Read ↗

Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.Semantic proximity Read ↗

The genomic architecture of antimalarial drug resistanceSemantic proximity Read ↗

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug DiscoverySemantic proximity Read ↗

Tackling resistance: emerging antimalarials and new parasite targets in the era of eliminationSemantic proximity Read ↗

Antimalarial Drug Resistance and Implications for the WHO Global Technical StrategySemantic proximity Read ↗

Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving ResistanceSemantic proximity Read ↗

Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa.Semantic proximity Read ↗

Understanding drug resistance in malaria parasites: Basic science for public healthSemantic proximity Read ↗

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Semantic proximity Read ↗

What are the effects of drug resistance on the global spread of malaria? A systematic literature reviewSemantic proximity Read ↗

Expanding the Antimalarial Drug Arsenal—Now, But How?Semantic proximity Read ↗

Resistance to Antimalarial Drugs: Molecular, Pharmacologic, and Clinical ConsiderationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.